Versions Compared

Old Version 1

changes.mady.by.user Steve Kopko

Saved on

compared with

New Version 2

changes.mady.by.user Steve Kopko

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Completed by:Steve Kopko 
Date Completed:

Name and Version of Project:

Short Form 36 Health Survey Acute, US Version 2.0 (SF36 V2.0 ACUTE); V1.0


BEFORE POSTING FOR PUBLIC REVIEW

  •  All internal review comments have been resolved and updated in JIRA.
  •  Supplement has been through copy-editing. This is no longer necessay for Public Review.
  •  The FDA priority list has been checked to see if the supplement is marked "yes".
    •  Not an FDA priority
    •  If the supplement is an FDA priority, it has gone through FDA review and additional copy-editing if there were extensive changes.
  •  The FDA disclaimer is in the supplement if they reviewed it and not in the supplement if it's not an FDA priority.
  •  Notify the SDS QRS Subteam that the supplements are ready for public review.
  •  Announcement has been prepared.
  •  Project Manager/Team Lead notified Ann White (Communications) at least 5 days before planned public review posting so she can review the announcement and post to the CDISC website.


BEFORE SENDING FOR NEXT STEPS PUBLICATION

  •  All public review comments have been resolved in JIRA.  If not, note above, do not put a check by the supplement name, and do not send on for the publication (will need to complete a separate public review checklist).
    •  Once all IR and PR comments are approved, mark them as "Done", export to Excel, and archive on the supplement archive page.
  •  Information boxes have been removed from supplement.
  •  All text is black except for links (which are blue).
  •  DRAFT or REVISION DRAFT has been changed to FINAL in document metadata.
  •  Revision History date and status has been updated.
  •  Supplement has been through final copy-editing step.
  •  WORD file of the supplement for publishing as a PDF has been reviewed
  •  The FDA priority list has been checked to see if the supplement is marked "yes".
    •  If the supplement is an FDA priority, it has gone through FDA quick review and additional copy-editing if there were extensive changes.
  •  Notify the SDS QRS Subteam that the supplements are ready for the publication stage.
  •  Announcement has been prepared.
  •  Project Manager/Team Lead notified Alana and Ann White (Communications) at least 5 days before planned posting to prepare for publication and posting to the CDISC website.